Drug intelligence / Profile preview

bovine collagen oligopeptide

Development stage
Unknown
Modality
Recombinant Proteins and Enzymes, Peptides
Administration
Oral
01

Overview

Bovine collagen oligopeptide refers to short-chain peptides derived from the enzymatic hydrolysis of type I and III collagens sourced from the hide, bones, or tendons of cows. These oligopeptides are highly bioavailable and are commonly used as dietary supplements in powder, capsule, or liquid form. They provide essential amino acids such as glycine and proline that support the synthesis of new collagen in human tissues. Bovine collagen oligopeptides are primarily used to promote skin elasticity and hydration, support joint health (including osteoarthritis), improve bone strength (osteoporosis), enhance muscle mass recovery after exercise, and may aid gut health. The mechanism of action is believed to involve providing building blocks for connective tissue repair and stimulating fibroblast activity for new extracellular matrix formation[1][2][3][4][5]. Bovine-derived collagens are considered generally recognized as safe by regulatory authorities when consumed appropriately[3].

Other names
bovine collagen peptidehydrolyzed bovine collagenbovine collagen peptidesbovine type I collagen
02

Targets

α10β1 (Integrin alpha 10 beta 1)DDR1 (Discoidin domain receptor 1)ERC (Elastin receptor complex)ITGA2/ITGB1 (Integrin alpha-2/beta-1 receptor)

Beyond the preview

Go deeper on bovine collagen oligopeptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bovine collagen oligopeptide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call